Nordic collaborative study of the <i>BARD1</i> Cys557Ser allele in 3956 patients with cancer: enrichment in familial <i>BRCA1</i>/<i>BRCA2</i> mutation-negative breast cancer but not in other malignancies - Concepedia

Concepedia

Publication | Open Access

Nordic collaborative study of the <i>BARD1</i> Cys557Ser allele in 3956 patients with cancer: enrichment in familial <i>BRCA1</i>/<i>BRCA2</i> mutation-negative breast cancer but not in other malignancies

DOI Full Paper Access

44

Citations

32

References

2006

Year

Sanna‐Maria Karppinen, Rósa B. Barkardóttir, Katja Backenhorn, Thomas Vognbjerg Sydenham, Kirsi Syrjäkoski, Johanna Schleutker, Tarja Ikonen, Katri Pylkäs, Katrin Rapakko, Hannele Erkko,

Journal of Medical Genetics

Abstract

These results provide further evidence that BARD1 Cys557Ser confers a slightly increased risk of breast cancer in women.

References

	Year	Citations
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene <i>BRCA1</i> Yoshio Miki, Jeffrey Swensen, Donna Shattuck-Eidens, Science Breast OncologyEngineeringGeneticsBrca1 GeneTumor Biology	1994	6.1K
Identification of the breast cancer susceptibility gene BRCA2 Richard Wooster, Graham R. Bignell, Jonathan Lancaster, Nature Breast OncologyCancer GenomicsBreast CancerCancer GeneticsMedicine	1995	3.6K
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families Deborah Ford, Douglas F. Easton, Michael R. Stratton, The American Journal of Human Genetics	1998	3K
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations Deborah J. Thompson, Richard S. Houlston, Catherine Phelan Nature Genetics Breast OncologyMedicineBrca2 MutationsPathologyCancer Genomics	2002	1.1K
Dynamic Changes of BRCA1 Subnuclear Location and Phosphorylation State Are Initiated by DNA Damage Ralph Scully, Junjie Chen, Robert Ochs, Cell ChromatinGenome InstabilityDynamic ChangesDna DamageChromatin Remodeling	1997	908
Polygenic susceptibility to breast cancer and implications for prevention Paul D.P. Pharoah, Antonis C. Antoniou, Martin Bobrow, Nature Genetics Breast OncologyPolygenic RiskPolygenic SusceptibilityPathologyBreast Cancer	2002	901
The genetic attributable risk of breast and ovarian cancer Elizabeth B. Claus, Joellen M. Schildkraut, W. Douglas Thompson, Cancer	1996	747
Identification of a RING protein that can interact in vivo with the BRCA1 gene product Leeju C. Wu, Zhuo Wei Wang, Julia Tsou Tsan, Nature Genetics Natural SciencesProtein GeneticsMolecular BiologyGene CharacterizationMolecular Genetics	1996	746
The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation Rintaro Hashizume, Mamoru Fukuda, Ichiro Maeda, Journal of Biological Chemistry	2001	635
Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. D Ford, Douglas F. Easton, Julian Peto PubMed	1995	537

Page 1